• CXI Healthcare Technology Group will buy 27,500 shares in AIDT Technologies for KRW 60.61 billion, taking a 55% stake.
• The deal values the purchase at USD 1,650 per share, totaling USD 45.375 million, paid in cash from internal funds.
• Completion is scheduled for Oct. 19, 2026, with AIDT set to become a consolidated subsidiary.
• AIDT develops vertical AI solutions in the data-to-AI segment, supporting CXI’s push into AI-related new businesses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CXI Healthcare Technology Group Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261013000370), on October 13, 2026, and is solely responsible for the information contained therein.